MEK

CAT # Inoa Huahana wehewehe
CPDB0157 BI-847325 ʻO BI-847325 he mea koho pālua MEK / Aurora kinase inhibitor me IC50 waiwai o 3, 25, 15, 25, a me 4 nM no X. laevis Aurora B, kanaka Aurora A a me Aurora C, a me kanaka MEK1 a me MEK2. Hiki iā ia ke keʻakeʻa i ka ulu a me ke ola ʻana o nā laina melanoma cell treatment-naive a me ka lāʻau lapaʻau, e hoʻemi ana i ka hōʻike ʻana o MEK a me Mcl-1 me ka hoʻonui ʻana i ka hōʻike o ka Bim protein pro-apoptotic. Ma ka 70 mg/kg, hoʻoulu ʻo BI-847325 i ka apoptosis i ka lāʻau lapaʻau-naive a me ka lāʻau lapaʻau xenografted melanoma i vivo.
,

Kāhea iā mā˚ou

Ninau

Nuhou Hou

  • ʻO 7 ʻoi loa ma ka noiʻi lāʻau lapaʻau ma 2018

    ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

    Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

  • ARS-1620: He mea hoʻohiki hou no nā maʻi maʻi KRAS-mutant

    ARS-1620: He mea hoʻohiki hou no K...

    Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke lilo i mutant KRAS ...

  • Loaʻa iā AstraZeneca ka hoʻoikaika kānāwai no nā lāʻau lapaʻau oncology

    Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

    Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

WhatsApp Online Chat !